Inhibition of the CDP-choline pathway during apoptosis restricts the availability of phosphatidylcholine (PtdCho) for assembly of membranes and synthesis of signaling factors.
INTRODUCTION
Phosphatidylcholine (PtdCho), a zwitterionic glycerophospholipid that comprises 40-60% of eukaryotic membrane mass, is an essential component of lung surfactant, bile and lipoproteins, and a source for signaling molecules such as diacylglycerol (DAG) and phosphatidic acid (1) . The de novo synthesis of PtdCho via the CDP-choline (Kennedy) pathway is initiated by choline transport into cells and subsequent phosphorylation by choline kinase (CK). Phosphocholine is converted to CDP-choline by the rate-limiting enzyme CTP:phosphocholine cytidylyltransferase (CCT), an amphitropic enzyme that is regulated by reversibly binding to membranes in response to changes in lipid composition (2) .
Finally, choline phosphotransferase (CPT) or choline/ethanolamine phosphotransferase (CEPT) in the Golgi and endoplasmic reticulum (ER), respectively, synthesize PtdCho from CDP-choline and DAG (3) . Since multiple enzyme isoforms catalyze each step in the pathway (reviewed in (4)), regulation and biosynthetic capacity is determined by unique developmental and tissue-specific patterns of enzyme expression. For example, knockout of the ubiquitous CCTα isoform in mice is embryonic lethal indicating an essential developmental role (5) . However, conditional
CCTα deletion in tissues that express sufficient CCTβ or phosphatidylethanolamine Nmethyltransferase is not lethal, resulting in phenotypes related to partial deduction in biosynthetic capacity (6) (7) (8) .
cytoplasmic membranes (27, 28) . CPT/CEPT is inhibited during apoptosis by cytotoxic drugs (29, 30), cellular acidification (30) and/or depletion of DAG (28, 31).
Overexpression of CEPT prevented farnesol-induced inhibition of PtdCho synthesis but not apoptosis, indicating that inhibition of CEPT and PtdCho synthesis may not be directly linked to this mode of cell death (32). Apoptosis has not been reported to affect CK or choline transport activity.
It is evident that inhibition of the CDP-choline pathway is a common feature of apoptotic programs. However, a primary mechanism involving inhibition of CCTα and/or CPT/CEPT is at odds with metabolic labeling studies that consistently showed a reduction in choline incorporation into the substrates and products of these enzymes (21, 28, 30). To reconcile this discrepancy we compared CCTα, CK and choline transport activities with the flux of radiolabelled choline through the CDP-choline pathway in apoptotic cells. This approach identified a caspase 3-dependent pathway for proteolysis and nuclear export of CCTα. However, caspase-3-dependent and -independent inhibition of choline transport was identified as the primarily mechanism for suppression of the CDP-choline pathway.
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Human embryonic kidney (HEK) 293 cells were cultured in DMEM containing 10% FCS (medium A). CHO-MT58 cells were cultured in DMEM with 5% FCS and proline (33 µg/ml). MCF7 cells stably expressing pBabe retroviral-encoded caspase 3 (MCF7-C3) or control vector (MCF7) were cultured in medium A containing puromycin (0.5 µg/ml) (kindly provided by Dr. Daum Tang, McMaster University ON). HEK293
and MCF7 cells were incubated in a 5% CO 2 atmosphere at 37˚C. CHO-MT58 cells were maintained at 32 o C but shifted to 42 o C after cDNA transfection to reduce the expression of the endogenous temperature-sensitive CCTα.
HEK293 cells were transfected using TransIT-TKO reagent with 30 nM (caspase 6), 100 nM (caspase 8) or 100 nM (caspases 3 and 7) siRNAs. After 24 h, medium A was replaced and cells were cultured for another 24 h prior to the start of experiments.
CHO-MT58 cells were transfected with pcDNA-CCT-V5/His or pcDNA-CCTΔ28-V5/His using Lipofectamine 2000 according to the manufacturer's instructions.
Fluorescence microscopy
CHO-MT58, MCF7 and MCF7-C3 cells (seeded on glass coverslips) were fixed in 4% paraformaldehyde in PBS for 10 min and quenched with 100 mM NH 4 Cl. Cells were permeabilized with 0.05% Triton X-100 (w/v) in PBS at 4˚C for 10 min and blocked in PBS with 1% BSA (w/v). All primary and Alexafluor-conjugated secondary
Images were captured using a Zeiss LSM510 Meta laser scanning confocal upright microscope with a plan-apochromat 100x/1.40 NA oil immersion objective.
Caspase cleavage of recombinant CCTα
CCTα and CCTα-D28E were in vitro transcribed/translated from pGEM4z-CCT and pGEM4z-CCTα-D28E using the T N T Coupled Reticulocyte Lysate System (Promega 
RESULTS

CCTα is a caspase 3 substrate
The NLS is removed from the N-terminus of CCTα by caspase cleavage at The results of the in vitro assay served as the basis to identify the CCTα-specific caspase(s) in apoptotic HEK293 cells. Based on evidence from our lab and others (27, 38), and preferred caspase consensus sites (39), caspases 3, 6, 7 and 8 were selected for analysis. Our inability to identify the involvement of individual caspases using pharmacological approaches (results not shown) prompted the use of siRNAs to silence caspases 3, 6, 7 and 8 in HEK293 cells induced to undergo apoptosis with chelerythrine, a protein kinase C inhibitor that also profoundly inhibits the CDP-choline pathway (30).
Caspase 6 displayed the highest activity toward CCTα in vitro and its major nuclear substrate is lamin A/C (40). Caspase 6 was silenced in HEK293 cells, apoptosis was induced with chelerythrine and the cleavage of lamin A/C and CCTα was examined by immunoblotting ( Fig. 2A ). The caspase 6 siRNA reduced protein expression by 81.5+6.7% (n=4) after 48 h ( Fig. 2A, Casp6 panel) . In caspase 6 knockdown cells, lamin A/C was poorly processed to its 28 kDa cleavage product compared to non-targeting controls. However, the time course for processing of CCTα was similar in control and caspase 6-depleted cells, and there was no significant difference in the distribution of full-length and processed forms at 4 h (Fig. 2D ). Caspase 8 is associated with the extrinsic death-receptor pathway but can also be activated through the intrinsic pathway (41) . The involvement of caspase 8 was tested by silencing its expression in HEK293 cells, followed by induction of apoptosis with chelerythrine ( Fig. 2B and C).
Immunoblotting showed a 91.4+5.6% (n=3) reduction in caspase 8 expression in nonapoptotic HEK293 cells after RNAi treatment for 48 h (Fig. 2C ). Cleavage of PARP was similar in apoptotic HEK293 cells transfected with non-targeting and caspase 8 siRNAs.
Similarly, caspase 8 silencing did not inhibit CCTα processing during chelerythrine treatment ( Fig. 2B and D) . To address the possibility that individual knockdown of caspase 6 and 8 did not eliminate CCTα processing due to redundancy, both caspases were simultaneously suppressed by RNAi, and CCTα processing was determined after induction of apoptosis in HEK293 cells for 4 h (Fig. 2E) 3A ). Compared to non-targeting controls, caspase 3 knockdown had only a minor effect on PARP processing after chelerythrine treatment for 4 h (Fig. 3B ). This was not unexpected since PARP is a substrate for other executioner caspases, including caspase 7 (42) (43) (44) . In contrast, caspase 3 depletion by both siRNAs inhibited CCTα processing at 2 and 4 h as indicated by reduction in the 37 kDa processed form and a reciprocal increase in the full-length enzyme ( This supports the conclusion that caspase 3 is responsible for CCTα processing and release from the nucleus.
Enzyme activity of the caspase-cleaved mimic CCTα-Δ28
Endogenous, caspase-cleaved CCTα is activated following induction of apoptosis with farnesol (27). However, farnesol is also a lipophilic activator of CCTα that increases membrane translocation and enzyme activity on liposomes and in cultured cells, making it difficult to directly determine the effect of N-terminal processing on enzyme activity. To assess whether caspase 3 processing affects CCTα activity independent of apoptotic induction, we assayed the activity of a constitutively cleaved mimic CCTα-Δ28. V5-tagged CCTα and CCTα-Δ28 had the expected molecular masses and were transiently expressed at similar levels in CHO-MT58 cells (Fig. 5A ).
Immunofluorescence analysis of transiently transfected CHO-MT58 cells showed that
CCTα was expressed primarily in the nucleoplasm while CCTα-Δ28 was distributed in both the nucleoplasm and cytoplasm (Fig. 5B ). To assess the activity of CCTα and (Fig. 8) . The rate of PtdCho synthesis was reduced by 50% in camptothecintreated MCF7 cells compared to untreated controls (26,390+7,320 versus 14,640+4,330 dpm/h, respectively) ( Fig. 8A and B) . There was a similar 50% reduction in the rate of consumption of phosphocholine. In untreated MCF7-C3 cells, the initial rate of PtdCho synthesis (11,680+5170 dpm/h) was reduced compared to untreated MCF7 cells, reflecting a larger pool of phospho[ 3 H]choline in these cells (Fig. 8C) . In camptothecintreated MCF7-C3 cells (Fig. 8D) , radiolabelled phosphocholine at the end of the pulse period (0 h) was reduced by 50% compared to untreated cells, and subsequent conversion Metabolic labeling of phosphocholine is reduced in apoptotic MCF7 and MCF7-C3 cells despite an apparent reduction in CCTα activity (Fig. 8) , which utilizes phosphocholine as a substrate. This suggests that the synthesis of phosphocholine is inhibited due to reduced choline transport and/or phosphorylation. CKα is the major isoform expressed in MCF7 cells and is overexpressed in many types of cancer (48) .
However, total CK activity in the cytosolic fractions from control and camptothecintreated MCF7 and MCF7-C3 cells was similar (Fig. 9) .
Choline is taken up into mammalian cells by the high-affinity, sodium-dependent family member is involved (Fig. 10B ). HC-3 was then used to determine whether intermediate-and/or low-affinity choline transporter activities are inhibited by camptothecin-induced apoptosis ( Fig. 10C and D) . For these experiments, the relative inhibition by camptothecin of HC-3-sensitive and -insensitive choline transporters was measured in MCF7 and MCF7-C3 cells. In the case of MCF7 cells, camptothecin significantly inhibited choline transport activity in the absence but not the presence of HC-3, suggesting that a HC-3-sensitive CTL was affected (Fig. 10C) . In contrast, camptothecin significantly inhibited approximately 70% of choline transport activity in MCF7-C3 cells in the absence and presence of HC-3. However, inhibition of the HC-3-sensitive transporter during apoptosis is more relevant since it accounts for >70% of activity in MCF7 cells. Thus reduced choline incorporation into PtdCho in apoptotic MCF7 and MCF7-C3 cells ( Fig. 7 and 8 ) is primarily due to caspase 3-independent anddependent inhibition of HC-3-sensitive CTL1 or related family members.
DISCUSSION
Perturbation of membrane structure by alterations in the composition and topology of the phospholipid constituents is an important feature of apoptotic programs.
In the case of PtdCho, synthesis by the CDP-choline pathway is inhibited (52), degradation by lipases is stimulated (53) and it is the source of the lysophosphatidylcholine 'eat me' signal (54) . Caspase processing of CCTα and inhibition of CEPT/CPT are implicated in the cessation of PtdCho synthesis but evidence is indirect and, based on radiolabeling experiments, the substrates for these enzymes (CDP-choline and phosphocholine) do not accumulate in apoptotic cells (28-30). In this study, we used two well-characterized apoptotic agents (camptothecin and chelerythrine) that strongly inhibit PtdCho synthesis to demonstrate that caspase 3 cleaves the nuclear localization signal from CCTα. However, metabolic labeling and in vitro assays revealed that transport of choline into cells is inhibited by caspase 3-dependent and independent mechanisms, leading to global suppression of choline incorporation into the CDP-choline pathway.
In vitro translated CCTα was a substrate for caspases 3, 6, 7, 8 and 9, but only caspase 3 was involved in processing the enzyme in cultured cells. The processing of in vitro translated CCTα by multiple caspases could be due to misfolding and loss of tertiary structure-specific context, lack of caspase substrate specificity in vitro (37), and/or loss of temporal and spatial regulatory elements in a cell-free system (43 NE localization of CCTα was not evident in camptothecin-treated MCF7-C3 cells, which also had reduced staining of the NPC indicating that cytoplasmis CCTα could have resulted from loss of NE integrity. In this context it is difficult to determine whether caspase 3 cleavage occurred prior to or after release of CCTα from the nucleus.
Nevertheless, it appears that NLS removal by caspase 3 is a mechanism to keep CCTα sequestered in the cytoplasm of apoptotic cells. The caspase-processed mimic CCTα-Δ28 was cytoplasmic, had increased PtdCho synthesis and the membrane-associated enzyme had a reduced Km for CTP. Cytoplasmic CCTα-Δ28 had similar kinetic parameters as wild-type suggesting that the increased activity of CCT-Δ28 results from activation on cytoplasmic membranes rather then a general stimulatory effect due to NLS deletion. *p<0.05 using a unpaired t-test compared to untreated cells. www.jlr.org
